Monetary Management Group’s Boston Scientific BSX Stock Holding History

Monetary Management Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$117K	Sell	1,860 -2,400	-56%	-$192K	0.03%	227
2025 Q4	$406K	Buy	4,260 +900	+27%	+$88.2K	0.09%	162
2025 Q3	$328K	Buy	3,360 +1,000	+42%	+$104K	0.08%	174
2025 Q2	$253K	Hold	2,360	–	–	0.06%	184
2025 Q1	$238K	Sell	2,360 -500	-17%	-$50.3K	0.06%	188
2024 Q4	$255K	Buy	+2,860	New	+$252K	0.07%	184

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Monetary Management Group's BSX Position: Q1 2026 in Review

Monetary Management Group reduced its Boston Scientific (BSX) stake by 56% in Q1 2026, selling an estimated $192K and leaving 1,860 shares worth $117K. The position accounts for 0.03% of the portfolio, ranked #227.

Monetary Management Group first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $406K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Monetary Management Group held 1,860 shares of Boston Scientific worth $117K as of Q1 2026.
Monetary Management Group sold 2,400 Boston Scientific shares in Q1 2026, an estimated $192K.
Boston Scientific made up 0.03% of Monetary Management Group's portfolio in Q1 2026, its #227 holding.
Monetary Management Group first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Monetary Management Group's Boston Scientific position peaked at $406K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Monetary Management Group's 13F filing for Q1 2026, filed 13 May 2026.